Market Tracker

03/06 3:45am ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.29
Delayed Data
As of Mar 05
 +0.13 / +6.02%
Today’s Change
1.00
Today|||52-Week Range
8.46
-10.20%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.16
Today’s open2.18
Day’s range-- - --
Volume1,140,270
Average volume (3 months)1,309,542
Market cap$133.8M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+27.47%
Earnings growth (this year)-35.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.93%
P/E ratioNM
Price/Sales31.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.36+6.96%
RNNRexahn Pharmaceutica...-0.01-1.28%
RDHLRedhill Biopharma Lt...+0.04+0.28%
AFMDAffimed NV+0.12+2.04%
Data as of 3:59pm ET, 03/05/2015

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$8.0M
Annual profit (last year)-$34.6M
Net profit margin-434.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts